Sign Up Today and Learn More About Joyn Bio Stock
Invest in or calculate the value of your shares in Joyn Bio or other pre-IPO companies through EquityZen's platform.
Joyn Bio Stock (JOBI)
A joint venture founded by Bayer and Ginkgo Bioworks developing probiotics for plants.
About Joyn Bio Stock
Headquarters
Boston, MA, US
Total Funding
100M
Industries
Professional Services, Science and Engineering, Agriculture and Farming
Joyn Bio is a joint venture founded by Bayer and Ginkgo Bioworks developing probiotics for plants to provide growers with next generation solutions to their biggest challenges. Joyn Bio’s first area of focus will be on engineering microbes that provide cereal crops with their nitrogen needs to reduce agriculture’s reliance on nitrogen fertilizer and its environmental impact. Joyn Bio brings together microbiologists, synthetic biologists, plant scientists, and ecologists at its headquarters in Boston, Massachusetts and its plant research facility in West Sacramento, California.
Joyn Bio Press Mentions
Stay in the know about the latest news on Joyn Bio
Joyn Bio aims to solve the world’s fertilizer problem with microbes
cnbc • May 22, 2022
Joyn Bio expands Woodland ag-tech research operation
bizjournals • Nov 13, 2021
4 Companies Replacing Nitrogen in Fertilizers
nanalyze • Aug 29, 2021
“One of the challenges is we have products that farmers are using and many of these products are not sustainable” : Joyn Bio CEO
finance • Feb 23, 2021
How Plant Sciences Will Feed 10 Billion People By 2050
nanalyze • Jun 08, 2019
Joyn Bio Management
Leadership team at Joyn Bio
Co-Founder
Jason Kelly
Join now and verify your accreditation status to gain access to:
- Joyn Bio current valuation
- Joyn Bio stock price
- Available deals in Joyn Bio and all other companies
- Deal offering documents
- EquityZen's proprietary data and insights, including
- Cap tables, which include funding history by Share Class and Liquidity Preferences
- Company Highlights
- Business Model
- Risk Factors
How to invest in Joyn Bio stock?
Accredited investors can buy pre-IPO stock in companies like Joyn Bio through EquityZen funds. These investments are made available by existing Joyn Bio shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Joyn Bio stock?
Shareholders can sell their Joyn Bio stock through EquityZen's private company marketplace. EquityZen's network includes over 330K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 43K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
